CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 242 enrolled
Drug / intervention
PressureWire Certus guidewiredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02325973
NCT02325973N/ACompleted
CompareCT.gov

Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI (AMICRO)

Abbott Medical Devices·interventional·Posted Dec 25, 2014·Updated Aug 8, 2025

In Brief

A clinical study evaluating PressureWire Certus guidewire for Multi Vessel Coronary Artery Disease and STEMI. Completed, enrolled 242 participants across 14 sites.

Detailed Summary

The purpose of this study is to assess whether the Index of Microcirculatory Resistance (IMR) can be considered a prognostic predictor for the occurrence of events at one year of follow up after primary Percutaneous Coronary Intervention (PCI) in ST-Elevation Myocardial Infarction (STEMI) patients. Any correlation between IMR and the short and medium term outcomes, defined as cardiovascular death, re-Myocardial Infarct (MI), re-hospitalization for Heart Failure (HF), resuscitation or Implantable Cardioverter Defibrillator (ICD) appropriate shock, will be assessed in the study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMulti Vessel Coronary Artery Disease, STEMI
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 25, 2014
Enrollment StartJun 1, 2013
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 11.5 years ago

Interventions

PressureWire Certus guidewiredevice

Assessment of IMR index in coronaries through PressureWire Certus guidewire